Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS – Neurofilament as a Surrogate of Disease Progression

Impact of Inflammation on Brain Volume in Multiple Sclerosis

(2012) Jojy Cheriyan   ARCHIVES OF NEUROLOGY

Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers

(2011) Maartje I. Kester et al.   NEUROBIOLOGY OF AGING

Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis

(2011) J. Kuhle et al.   NEUROLOGY

Psychometrics of Dominant Right Hand During the 9-Hole Peg Test: Differences Between Peg Placement and Removal

(2011) Tetsuo Koyama et al.   PM&R

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial

(2010) Raju Kapoor et al.   LANCET NEUROLOGY

Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter

(2009) Marco Vercellino et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

(2009) C. E. Teunissen et al.   NEUROLOGY

Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease

(2008) Valerio Leoni et al.   BRAIN